CDC25c expression in patients with myelofibrosis is associated with stronger myeloproliferation and shorter overall survival.
Davor GalusicMarko LucijanicAna LivunMaja RadmanJelena LucijanicIrena Drmic HofmanRajko KusecPublished in: Wiener klinische Wochenschrift (2020)
Our data suggest that higher CDC25c expression is associated with more proliferative phenotype of myelofibrosis and is prognostic of worse survival. Future studies investigating these interesting associations are warranted.